Clinical Pharmacology & Therapeutics · 1982 · 48 citations · 0 references
PharmacyPharmacokineticsPharmacologyDrug ClearanceRenal PharmacokineticsRenal PharmacotherapyDrug DispositionPharmacokinetics In Renal ImpairmentRenal Drug ClearanceRenal PharmacologyClinical Pharmacology EvidenceExtrarenal EliminationNifedipine TherapyRenal Blood ClearanceRenal Clearance EffectsUrinary Drug RecoveryUrinary Recovery Of DrugsVerapamil Therapy
Verapamil has been shown to reduce total-body digoxin clearance by 35% due to impairments of both renal and extrarenal clearances. Our study was undertaken to evaluate the influence of the related calcium antagonist nifedipine on single-dose kinetics. Nifedipine increased extrarenal clearance of digoxin from 1.09 +/- 0.30(SD) to 1.45 +/- 0.23 ml/min/kg (P less than 0.05) and reduced the total urinary recovery of the drug from 69.2% +/- 5.9(SD) to 64.3% +/- 5.2 (P less than 0.05). There were no significant changes in renal digoxin clearance, distribution, or biological half-life or in digoxin distribution volumes during nifedipine coadministration.